Gilead Sciences Inc (GILD)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$115.10
Buy
$115.62
$0.70 (+0.61%)
Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.
Prices updated at 06 Mar 2025, 00:59 EST
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Annual report | Feb 2026 |
| Final results | Feb 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | May 2025 |
| Previous date | |
|---|---|
| Annual report | Feb 2025 |
| Final results | Feb 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | May 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 